Skip to content

To study the effectiveness of a test product on volunteers with acne scars

A single arm, open label, prospective, study of a Test Product in participants with post acne scars.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039598
Enrollment
30
Registered
2022-01-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Bye bye acne scar gel: Product to be applied on clean face. Apply sufficient quantity of product on entire face. Product to be applied twice daily- morning after bath and night before b

Sponsors

Amvigor Organics Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Voluntary men and/or women in the age group of 18 to 45 years. 2. Volunteers with acne scars 3. Patients without any scar treatment done in the past 6 months. 4. Having signed a Consent Form after being informed orally and in writing of all information concerning the study procedures and study objectives. 5. Ready to comply with the study specifications. 6. Willing to refrain from use of all other topical medications that would affect the results of the trial. 7.No history of allergic dermatitis or contact allergy to cosmetics.

Exclusion criteria

Exclusion criteria: 1. Pregnant women confirmed by UPT , Lactating mothers. 2. Participants with hypertropic acne scars. 3. Known sensitivity to any of the ingredients in the study product. 4. Presence of other skin conditions, diseases, or medical conditions that (per protocol or in the opinion of the Investigator) may require concurrent therapy, interfere with the evaluation of the study medication, or compromise participant safety.

Design outcomes

Primary

MeasureTime frame
1. Change in depth of acne scars using 3D Imaging. 2. Clinical Photography to observe the change in depth of acne scars 3. Subject self evaluation questionnaireTimepoint: Day 0, Day 28, Day 56

Secondary

MeasureTime frame
To evaluate the in-use tolerance of the Product via clinical evaluation and self assessment questionnaireTimepoint: Day 0, Day 28, Day 56

Countries

India

Contacts

Public ContactDr Ragni Desai Manager

AMVIGOR ORGANICS PVT. LTD

technical@amvigororganics.com68698822

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026